Although iCAFs downregulated TGFB3 during treatment compared to pre-treatment, they may still promote monocyte survival and differentiation into tumor-associated macrophages by overexpressing macrophage colony-stimulating factor-1 (CSF-1) [46–48] (Fig. 5g and h). Here, TGFB3 is linked to neoplasm.